Cefixime is a cephalosporin antibacterial indicated in the treatment of adults and pediatric patients six months of age or older with the following infections when caused by susceptible isolates of the designated bacteria:
Uncomplicated Urinary Tract Infections
Uncomplicated Urinary Tract Infections caused by Escherichia coli and Proteus mirabilis.
Otitis Media caused by Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pyogenes. (Efficacy for Streptococcus pyogenes in this organ system was studied in fewer than 10 infections.)
Note: For patients with otitis media caused by Streptococcus pneumoniae, overall response was approximately 10% lower for cefixime than for the comparator.
Pharyngitis and Tonsillitis
Pharyngitis and Tonsillitis caused by Streptococcus pyogenes.
Acute Exacerbations of Chronic Bronchitis
Acute Exacerbations of Chronic Bronchitis caused by Streptococcus pneumoniae and Haemophilus influenzae.
Uncomplicated Gonorrhea (cervical/urethral)
Uncomplicated Gonorrhea (cervical/urethral) caused by Neisseria gonorrhoeae (penicillinase-and non-penicillinase-producing isolates).
Tablets : 200mg
Capsule : 400mg
Dry Suspension : 100mg/5ml
DS Dry Suspension: 200mg/5ml
Tablets : 10’s
Capsule : 5’s
Dry Suspension : 30ml & 60ml
DS Dry Suspension : 30ml
Tablet, Capsule & Dry Suspension